This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Zacks.com featured highlights include J.Jill, Option Care Health and Amphenol
by Zacks Equity Research
J.Jill, Option Care Health and Amphenol have been highlighted in this Screen of The Week article.
3 Stocks Backed by High Efficiency to Boost Portfolio Returns
by Santanu Roy
Invest in stocks of J.Jill (JILL), Option Care Health (OPCH) and Amphenol (APH) to tap their high-efficiency levels.
New Strong Buy Stocks for June 10th
by Zacks Equity Research
NEM, ODP, IMMR, WSM and OPCH have been added to the Zacks Rank #1 (Strong Buy) List on June 10, 2024.
Buy These 3 Beaten-Down MedTech Stocks for a Turnaround Soon
by Moumi Mondal
Investing in beaten-down stocks like OPCH, LNTH and HOLX can be profitable for investors in the long term.
Option Care (OPCH) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Option Care (OPCH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
3 Highly Ranked Medical Stocks Added to the Zacks Strong Buy List
by Shaun Pruitt
Considering the stretched premiums many groundbreaking healthcare companies can command, these medical stocks are worthy of investors' interest given their attractive P/E valuations and the positive trend of earnings estimate revisions.
Zacks Industry Outlook Highlights DaVita, Encompass Health, Option Care Health and The Pennant Group
by Zacks Equity Research
DaVita, Encompass Health, Option Care Health and The Pennant Group have been highlighted in this Industry Outlook article.
Zacks.com featured highlights include Option Care Health, Merchants, Teekay Tankers and GigaCloud
by Zacks Equity Research
Option Care Health, Merchants, Teekay Tankers and GigaCloud have been highlighted in this Screen of The Week article.
4 Stocks to Buy in a Thriving Outpatient Home Health Industry
by Debanjana Dey
Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, EHC, OPCH and PNTG are well-poised to gain.
3 Stocks Backed by High Efficiency to Strengthen Your Portfolio
by Santanu Roy
Invest in companies like Option Care Health (OPCH), ReWalk Robotics Ltd. (LFWD) and Garmin (GRMN), as they boast higher efficiency levels.
The Zacks Analyst Blog Highlights DaVita, Option Care Health, Addus HomeCare, Encompass Health and The Pennant
by Zacks Equity Research
DaVita, Option Care Health, Addus HomeCare, Encompass Health and The Pennant are included in this Analyst Blog.
4 Must-Buy Profitable Stocks Using Net Income Ratio
by Tirthankar Chakraborty
Option Care Health (OPCH), Merchants Bancorp (MBIN), Teekay Tankers (TNK), and GigaCloud Technology (GCT) have been selected as the top picks with a high net income ratio.
Top 5 Outpatient and Home Healthcare Stocks for Solid Returns
by Nalak Das
We have narrowed our search to outpatient and home healthcare stocks that have strong growth potential for 2024. These are: DVA, ADUS, OPCH, EHC, PNTG.
Option Care (OPCH) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Option Care (OPCH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Are Investors Undervaluing Option Care Health (OPCH) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Option Care (OPCH) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Option Care (OPCH) delivered earnings and revenue surprises of 18.18% and 4.30%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Will Option Care (OPCH) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Option Care (OPCH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Option Care (OPCH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Option Care (OPCH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Option Care (OPCH) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Option Care (OPCH) delivered earnings and revenue surprises of 10.34% and 2.93%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Option Care (OPCH) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
Option Care (OPCH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
4 Stocks to Watch in a Resilient Outpatient Home Health Industry
by Debanjana Dey
The rising dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DVA, EHC, OPCH and ADUS are well-poised to gain.
These 4 Stocks Boast Impressive Interest Coverage Ratio
by Sumit Singh
A company capable of generating earnings well above its interest expense can withstand financial hardship. LRN, MOD, AMZN and OPCH are in a strong enough position to meet financial obligations.
Pick These 4 Stocks With Amazing Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. MOH, ATO, AMZN and OPCH are sound enough to meet financial obligations.
Zacks Industry Outlook Highlights DaVita, Option Care Health, Addus HomeCare and Pennant
by Zacks Equity Research
DaVita, Option Care Health, Addus HomeCare and Pennant have been highlighted in this Industry Outlook article.
4 Stocks to Watch in an Evolving Outpatient Home Health Industry
by Debanjana Dey
Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, OPCH, ADUS and PNTG are well-poised to gain.